DAXOR CORP (DXR) — Institutional Holders, Q2 2026
15 institutional investment managers reported a DXR position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $4.3M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
DXR in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- SUSQUEHANNA INTERNATIONAL GROUP, LLPAdded · +13,411 sh+$138.1K
- THOMPSON SIEGEL & WALMSLEYAdded · +9,647 sh+$99.3K
- Crescent Grove AdvisorsAdded · +1,700 sh+$17.5K
- RENAISSANCE TECHNOLOGIESAdded · +1,410 sh+$14.5K
- VANGUARD CAPITAL MANAGEMENTAdded · +551 sh+$5.7K
Biggest sellers
- Empirical Financial Services, d.b.a. Empirical Wealth MaSold out · -25,192 sh-$259.3K
- Aristides CapitalTrimmed · -3 sh-$31.00
DXR 13F holders ranked 1–15 of 15
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | THOMPSON SIEGEL & WALMSLEY#1 · 241,767 sh | 241,767 | $2.5M | 0.04% | +4.2% |
| 2 | VANGUARD CAPITAL MANAGEMENT#2 · 48,831 sh | 48,831 | $495.6K | 0.00% | +1.1% |
| 3 | Aristides Capital#3 · 41,689 sh | 41,689 | $429.2K | 0.08% | 0.0% |
| 4 | RENAISSANCE TECHNOLOGIES#4 · 29,421 sh | 29,421 | $302.9K | <0.01% | +5.0% |
| 5 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#5 · 27,131 sh | 27,131 | $275.4K | 0.00% | +97.7% |
| 6 | NANO CAP NEW MILLENNIUM GROWTH FUND L P#6 · 12,500 sh | 12,500 | $128.7K | 0.10% | 0.0% |
| 7 | Crescent Grove Advisors#7 · 12,423 sh | 12,423 | $127.9K | — | +15.9% |
| 8 | SBI Securities , Ltd.#8 · 3,131 sh | 3,131 | $32.2K | — | +0.1% |
| 9 | MORGAN STANLEY#9 · 3,087 sh | 3,087 | $31.8K | 0.00% | 0.0% |
| 10 | VANGUARD FIDUCIARY#10 · 1,037 sh | 1,037 | $10.5K | 0.00% | 0.0% |
| 11 | OSAIC#11 · 500 sh | 500 | $5.1K | 0.00% | 0.0% |
| 12 | Tower Research Capital (TRC)#12 · 305 sh | 305 | $3.1K | <0.01% | +179.8% |
| 13 | UBS Group AG#13 · 172 sh | 172 | $1.8K | 0.00% | New |
| 14 | JPMORGAN CHASE#14 · 6 sh | 6 | $61.00 | 0.00% | +500.0% |
| 15 | WELLS FARGO & COMPANY#15 · 0 sh | 0 | $2.00 | 0.00% | New |
Funds that sold out of DXR in Q2 2026 (1)
Held DXR at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Empirical Financial Services, d.b.a. Empirical Wealth Ma25,192 sh | 25,192 | $244.9K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.